Common Stock, Shares Authorized of Lexaria Bioscience Corp. from 31 Oct 2010 to 30 Nov 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Lexaria Bioscience Corp. quarterly Common Stock, Shares Authorized in shares history and change rate from 31 Oct 2010 to 30 Nov 2025.
  • Lexaria Bioscience Corp. Common Stock, Shares Authorized for the quarter ending 30 Nov 2025 was 220,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Lexaria Bioscience Corp. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 220,000,000 0 0% 30 Nov 2025 10-Q 13 Jan 2026 2026 Q1
Q3 2025 220,000,000 0 0% 31 Aug 2025 10-K 28 Nov 2025 2025 FY
Q2 2025 220,000,000 0 0% 31 May 2025 10-Q 14 Jul 2025 2025 Q3
Q1 2025 220,000,000 0 0% 28 Feb 2025 10-Q 14 Apr 2025 2025 Q2
Q4 2024 220,000,000 0 0% 30 Nov 2024 10-Q 10 Jan 2025 2025 Q1
Q3 2024 220,000,000 0 0% 31 Aug 2024 10-Q 13 Jan 2026 2026 Q1
Q2 2024 220,000,000 0 0% 31 May 2024 10-Q 12 Jul 2024 2024 Q3
Q1 2024 220,000,000 0 0% 29 Feb 2024 10-Q 09 Apr 2024 2024 Q2
Q4 2023 220,000,000 0 0% 30 Nov 2023 10-Q 12 Jan 2024 2023 Q1
Q3 2023 220,000,000 0 0% 31 Aug 2023 10-K 26 Nov 2024 2024 FY
Q2 2023 220,000,000 0 0% 31 May 2023 10-Q 14 Jul 2023 2023 Q3
Q1 2023 220,000,000 0 0% 28 Feb 2023 10-Q 14 Apr 2023 2023 Q2
Q4 2022 220,000,000 0 0% 30 Nov 2022 10-Q/A 18 Jan 2023 2023 Q1
Q3 2022 220,000,000 0 0% 31 Aug 2022 10-K 20 Nov 2023 2023 FY
Q2 2022 220,000,000 0 0% 31 May 2022 10-Q 14 Jul 2022 2022 Q3
Q1 2022 220,000,000 0 0% 28 Feb 2022 10-Q 11 Apr 2022 2022 Q2
Q4 2021 220,000,000 0 0% 30 Nov 2021 10-Q 14 Jan 2022 2022 Q1
Q3 2021 220,000,000 0 0% 31 Aug 2021 10-K 28 Nov 2022 2022 FY
Q2 2021 220,000,000 0 0% 31 May 2021 10-Q 15 Jul 2021 2021 Q3
Q1 2021 220,000,000 0 0% 28 Feb 2021 10-Q 14 Apr 2021 2021 Q2
Q4 2020 220,000,000 0 0% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 220,000,000 0 0% 31 Aug 2020 10-K 29 Nov 2021 2021 FY
Q2 2020 220,000,000 0 0% 31 May 2020 10-Q 29 Jun 2020 2020 Q3
Q1 2020 220,000,000 0 0% 29 Feb 2020 10-Q 03 Apr 2020 2020 Q2
Q4 2019 220,000,000 0 0% 30 Nov 2019 10-Q 09 Jan 2020 2020 Q1
Q3 2019 220,000,000 0 0% 31 Aug 2019 10-K 15 Oct 2020 2020 FY
Q2 2019 220,000,000 0 0% 31 May 2019 10-Q 08 Jul 2019 2019 Q3
Q1 2019 220,000,000 0 0% 28 Feb 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 220,000,000 0 0% 30 Nov 2018 10-Q 11 Jan 2019 2019 Q1
Q3 2018 220,000,000 0 0% 31 Aug 2018 10-K 14 Nov 2019 2019 FY
Q2 2018 220,000,000 0 0% 31 May 2018 10-Q 13 Jul 2018 2018 Q3
Q1 2018 220,000,000 0 0% 28 Feb 2018 10-Q 12 Apr 2018 2018 Q2
Q4 2017 220,000,000 0 0% 30 Nov 2017 10-Q 12 Jan 2018 2018 Q1
Q3 2017 220,000,000 0 0% 31 Aug 2017 10-K 14 Nov 2018 2018 FY
Q2 2017 220,000,000 0 0% 31 May 2017 10-Q 14 Jul 2017 2017 Q3
Q1 2017 220,000,000 0 0% 28 Feb 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 220,000,000 +20,000,000 +10% 30 Nov 2016 10-Q 13 Jan 2017 2017 Q1
Q3 2016 220,000,000 0 0% 31 Aug 2016 10-K 27 Nov 2017 2017 FY
Q2 2016 220,000,000 +20,000,000 +10% 31 May 2016 10-Q 13 Jul 2016 2016 Q3
Q1 2016 220,000,000 +20,000,000 +10% 29 Feb 2016 10-Q 13 Apr 2016 2016 Q2
Q4 2015 200,000,000 0 0% 30 Nov 2015 10-Q 08 Jan 2016 2016 Q1
Q3 2015 220,000,000 +20,000,000 +10% 31 Aug 2015 10-K 29 Nov 2016 2016 FY
Q2 2015 200,000,000 0 0% 31 May 2015 10-Q 14 Jul 2015 2015 Q3
Q1 2015 200,000,000 0 0% 28 Feb 2015 10-Q 14 Apr 2015 2015 Q2
Q4 2014 200,000,000 0 0% 30 Nov 2014 10-Q 14 Jan 2015 2015 Q1
Q3 2014 200,000,000 0 0% 31 Aug 2014 10-K 27 Nov 2015 2015 FY
Q2 2014 200,000,000 0 0% 31 Jul 2014 10-Q 14 Nov 2014 2014 Q3
Q1 2014 200,000,000 0 0% 30 Apr 2014 10-Q 12 Jun 2014 2014 Q2
Q4 2013 200,000,000 0 0% 31 Jan 2014 10-Q 12 Mar 2014 2014 Q1
Q3 2013 200,000,000 0 0% 31 Oct 2013 10-KT 09 Dec 2014 2014 FY
Q2 2013 200,000,000 0 0% 31 Jul 2013 10-Q 10 Sep 2013 2013 Q3
Q1 2013 200,000,000 0 0% 30 Apr 2013 10-Q 12 Jun 2013 2013 Q2
Q4 2012 200,000,000 0 0% 31 Jan 2013 10-Q 13 Mar 2013 2013 Q1
Q3 2012 200,000,000 0 0% 31 Oct 2012 10-K 24 Jan 2014 2013 FY
Q2 2012 200,000,000 0 0% 31 Jul 2012 10-Q 12 Sep 2012 2012 Q3
Q1 2012 200,000,000 30 Apr 2012 10-Q 07 Jun 2012 2012 Q2
Q4 2011 200,000,000 31 Jan 2012 10-Q 13 Mar 2012 2012 Q1
Q3 2011 200,000,000 0 0% 31 Oct 2011 10-K 29 Jan 2013 2012 FY
Q2 2011 200,000,000 31 Jul 2011 10-Q 14 Sep 2011 2011 Q3
Q3 2010 200,000,000 31 Oct 2010 10-K 30 Jan 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.